Widespread global disruption in routine childhood immunization has had a global effect, leaving an additional
3.7 million children missing basic vaccinations compared to pre-COVID-19 pandemic numbers.1
As part of a longer interview on vaccine acceptance (available here), Dr Angus Thomson (Irimi Company, Lyon, France) discusses the global uptake of COVID-19 vaccination, the impact the COVID-19 pandemic has had on the gains made over the past decade in increasing immunization, and outbreaks that can be linked back to a drop in immunizations.
Interviews available in this series:
- How has the COVID-19 pandemic impacted routine immunization programs? (0:50)
Disclosures: Dr Angus Thomson is a consultant for UNICEF, and Sabin Vaccine Institute.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
- World Health Organisation. Immunization coverage. Available at: www.who.int/news-room/fact-sheets/detail/immunization-coverage (accessed 4 October 2022).
Share this Video
Related Videos In Vaccines
Ruth Link-Gelles, IDWeek 2022: Efficacy of COVID-19 vaccination in paediatric populations
In this touchINFECTIOUS DISEASES interview, we met with Dr Ruth Link-Gelles (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) to discuss the incidence of COVID-19 in children, vaccine effectiveness against infection and disease severity, and the current status of paediatric COVID-19 vaccines in the United States. Interviews available in this series: Real world […]
Ruth Link-Gelles, IDWeek 2022: Real world effectiveness of paediatric COVID-19 vaccination
COVID-19 typically causes less severe illness and fewer deaths in children and adolescents compared to adults. Nonetheless, children and adolescents remain susceptible to COVID-19 infection and can transmit to others. In this touchINFECTIOUS DISEASES interview, we met with Dr Ruth Link-Gelles (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) to discuss real-world findings of […]
Michael Ison, IDWeek 2022: Respiratory syncytial virus (RSV) – Health burden and current vaccine candidates
Respiratory syncytial virus (RSV) present a significant disease burden in children and older adults. Currently, there are no approved vaccines against RSV. In this touchINFECTIOUS DISEASES interview, we met with Prof. Michael Ison (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss the health burden of RSV infection in older adults, and current […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!